Literature DB >> 22706349

MScreen: an integrated compound management and high-throughput screening data storage and analysis system.

Renju T Jacob1, Martha J Larsen, Scott D Larsen, Paul D Kirchhoff, David H Sherman, Richard R Neubig.   

Abstract

High-throughput screening (HTS) has historically been used by the pharmaceutical industry to rapidly test hundreds of thousands of compounds to identify potential drug candidates. More recently, academic groups have used HTS to identify new chemical probes or small interfering RNA (siRNA) that can serve as experimental tools to examine the biology or physiology of novel proteins, processes, or interactions. HTS presents a significant challenge with the vast and complex nature of data generated. This report describes MScreen, a Web-based, open-source cheminformatics application for chemical library and siRNA plate management, primary HTS and dose-response data handling, structure search, and administrative functions. Each project in MScreen can be secured with passwords or shared in an open-information environment that enables collaborators to easily compare data from many screens, providing a useful means to identify compounds with desired selectivity. Unique features include compound, substance, mixture, and siRNA plate creation and formatting; automated dose-response fitting and quality control (QC); and user, target, and assay method administration. MScreen provides an effective means to facilitate HTS information handling and analysis in the academic setting so that users can efficiently view their screening data and evaluate results for follow-up.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706349      PMCID: PMC3600606          DOI: 10.1177/1087057112450186

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  13 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Nonleadlikeness and leadlikeness in biochemical screening.

Authors:  Gilbert M Rishton
Journal:  Drug Discov Today       Date:  2003-01-15       Impact factor: 7.851

3.  Complementary cell-based high-throughput screens identify novel modulators of the unfolded protein response.

Authors:  Andrew M Fribley; Patricia G Cruz; Justin R Miller; Michael U Callaghan; Peter Cai; Neha Narula; Richard R Neubig; Hollis D Showalter; Scott D Larsen; Paul D Kirchhoff; Martha J Larsen; Douglas A Burr; Pamela J Schultz; Renju R Jacobs; Giselle Tamayo-Castillo; David Ron; David H Sherman; Randal J Kaufman
Journal:  J Biomol Screen       Date:  2011-08-15

Review 4.  Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology.

Authors:  Natasha Thorne; James Inglese; Douglas S Auld
Journal:  Chem Biol       Date:  2010-06-25

Review 5.  Open access high throughput drug discovery in the public domain: a Mount Everest in the making.

Authors:  Anuradha Roy; Peter R McDonald; Sitta Sittampalam; Rathnam Chaguturu
Journal:  Curr Pharm Biotechnol       Date:  2010-11       Impact factor: 2.837

6.  Identification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses.

Authors:  Weiping Peng; Daniel C Peltier; Martha J Larsen; Paul D Kirchhoff; Scott D Larsen; Richard R Neubig; David J Miller
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

7.  Polyplexed flow cytometry protein interaction assay: a novel high-throughput screening paradigm for RGS protein inhibitors.

Authors:  David L Roman; Shodai Ota; Richard R Neubig
Journal:  J Biomol Screen       Date:  2009-06-16

8.  Median absolute deviation to improve hit selection for genome-scale RNAi screens.

Authors:  Namjin Chung; Xiaohua Douglas Zhang; Anthony Kreamer; Louis Locco; Pei-Fen Kuan; Steven Bartz; Peter S Linsley; Marc Ferrer; Berta Strulovici
Journal:  J Biomol Screen       Date:  2008-01-23

9.  Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.

Authors:  Tomoko Komiyama; Julia M Coppola; Martha J Larsen; Marcian E van Dort; Brian D Ross; Robert Day; Alnawaz Rehemtulla; Robert S Fuller
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

10.  Screensaver: an open source lab information management system (LIMS) for high throughput screening facilities.

Authors:  Andrew N Tolopko; John P Sullivan; Sean D Erickson; David Wrobel; Su L Chiang; Katrina Rudnicki; Stewart Rudnicki; Jennifer Nale; Laura M Selfors; Dara Greenhouse; Jeremy L Muhlich; Caroline E Shamu
Journal:  BMC Bioinformatics       Date:  2010-05-18       Impact factor: 3.169

View more
  23 in total

1.  Narrow-spectrum inhibitors of Campylobacter jejuni flagellar expression and growth.

Authors:  Jeremiah G Johnson; Caroline Yuhas; Thomas J McQuade; Martha J Larsen; Victor J DiRita
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

2.  Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex.

Authors:  Alberto Jiménez-Somarribas; Shuli Mao; Jeong-Joong Yoon; Marco Weisshaar; Robert M Cox; Jose R Marengo; Deborah G Mitchell; Zachary P Morehouse; Dan Yan; Ivan Solis; Dennis C Liotta; Michael G Natchus; Richard K Plemper
Journal:  J Med Chem       Date:  2017-03-13       Impact factor: 7.446

3.  Genome-Wide Small Interfering RNA Screening Reveals a Role for Cullin3-Really Interesting New Gene Ligase Signaling in Heterologous Sensitization of Adenylyl Cyclase.

Authors:  Zhong Ding; Karin F K Ejendal; Monica Soto-Velasquez; Michael P Hayes; Nicholas Santoro; Martha J Larsen; Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2019-12-19       Impact factor: 4.030

Review 4.  The role of HTS in drug discovery at the University of Michigan.

Authors:  Martha J Larsen; Scott D Larsen; Andrew Fribley; Jolanta Grembecka; Kristoff Homan; Anna Mapp; Andrew Haak; Zaneta Nikolovska-Coleska; Jeanne A Stuckey; Duxin Sun; David H Sherman
Journal:  Comb Chem High Throughput Screen       Date:  2014-03       Impact factor: 1.339

5.  Microscale Adaptation of In Vitro Transcription/Translation for High-Throughput Screening of Natural Product Extract Libraries.

Authors:  Andrew N Lowell; Nicholas Santoro; Steven M Swaney; Thomas J McQuade; Pamela J Schultz; Martha J Larsen; David H Sherman
Journal:  Chem Biol Drug Des       Date:  2015-07-25       Impact factor: 2.817

6.  Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.

Authors:  Maria do Carmo Costa; Naila S Ashraf; Svetlana Fischer; Yemen Yang; Emily Schapka; Gnanada Joshi; Thomas J McQuade; Rahil M Dharia; Mark Dulchavsky; Michelle Ouyang; David Cook; Duxin Sun; Martha J Larsen; Jason E Gestwicki; Sokol V Todi; Magdalena I Ivanova; Henry L Paulson
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

7.  High-throughput screens for agonists of bone morphogenetic protein (BMP) signaling identify potent benzoxazole compounds.

Authors:  Shayna T J Bradford; Egon J Ranghini; Edward Grimley; Pil H Lee; Gregory R Dressler
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

8.  Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents.

Authors:  Jessica L Bell; Andrew J Haak; Susan M Wade; Paul D Kirchhoff; Richard R Neubig; Scott D Larsen
Journal:  Bioorg Med Chem Lett       Date:  2013-05-07       Impact factor: 2.823

9.  Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.

Authors:  Dan Yan; Marco Weisshaar; Kristen Lamb; Hokyung K Chung; Michael Z Lin; Richard K Plemper
Journal:  Biochemistry       Date:  2015-09-01       Impact factor: 3.162

10.  Comprehensive analysis of high-throughput screens with HiTSeekR.

Authors:  Markus List; Steffen Schmidt; Helle Christiansen; Marc Rehmsmeier; Qihua Tan; Jan Mollenhauer; Jan Baumbach
Journal:  Nucleic Acids Res       Date:  2016-06-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.